Utama › Sklerosis Pelbagai
Kajian klinikal Sklerosis Pelbagai sedang mengambil peserta di AS
131 kajian untuk Sklerosis Pelbagai sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY17 kajian
- Chicago, IL15 kajian
- Boston, MA14 kajian
- Washington, DC13 kajian
- Cleveland, OH9 kajian
- St. Louis, MO8 kajian
- Kansas City, KS8 kajian
- Birmingham, AL8 kajian
- San Francisco, CA8 kajian
- Columbus, OH7 kajian
- Aurora, CO7 kajian
- Baltimore, MD7 kajian
- Farmington Hills, MI6 kajian
- Seattle, WA6 kajian
- Dallas, TX6 kajian
- Houston, TX6 kajian
- Milwaukee, WI6 kajian
- Tampa, FL5 kajian
- San Diego, CA5 kajian
- Atlanta, GA5 kajian
- Austin, TX5 kajian
- Knoxville, TN4 kajian
- Naples, FL4 kajian
- Scottsdale, AZ4 kajian
- Brockton, MA4 kajian
- Durham, NC4 kajian
- New Haven, CT4 kajian
- Ann Arbor, MI4 kajian
- Orlando, FL4 kajian
- Miami, FL4 kajian
- Champaign, IL4 kajian
- Clifton, NJ3 kajian
- Rochester, MN3 kajian
- Philadelphia, PA3 kajian
- Cincinnati, OH3 kajian
- Kirkland, WA3 kajian
- Buffalo, NY3 kajian
- Raleigh, NC3 kajian
- Honolulu, HI3 kajian
- Omaha, NE3 kajian
Mengikut negeri
- Alabama8 kajian
- Arizona6 kajian
- California24 kajian
- Colorado11 kajian
- Connecticut6 kajian
- Florida14 kajian
- Georgia7 kajian
- Hawaii3 kajian
- Illinois19 kajian
- Kansas9 kajian
- Kentucky3 kajian
- Maryland17 kajian
- Massachusetts18 kajian
- Michigan10 kajian
- Minnesota4 kajian
- Missouri8 kajian
- Nebraska3 kajian
- New Jersey11 kajian
- New York19 kajian
- North Carolina8 kajian
- Ohio14 kajian
- Oklahoma3 kajian
- Pennsylvania7 kajian
- Tennessee6 kajian
- Texas17 kajian
- Utah3 kajian
- Virginia3 kajian
- Washington10 kajian
- Wilayah Columbia4 kajian
- Wisconsin7 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Mengambil pesertaFasa 1/2
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT03109288A Study of the MIND Diet for Persons With Multiple Sclerosis
Mengambil peserta
Umur 18 hingga 70 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06992115Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
1 Month – 99 Years · Semua jantina · Dikemas kini 2 Okt 2026 · NCT00794352A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06782490A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Mengambil pesertaFasa 4
Umur 18 hingga 65 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07609719Vancomycin Study in Multiple Sclerosis (MS)
Mengambil pesertaFasa 1
Umur 18 hingga 50 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05539729A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07840326Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
Mengambil peserta
Umur 18 hingga 64 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07475377Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06433752Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Mengambil pesertaFasa 1/2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07477639A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
Mengambil pesertaKajian pemerhatian
Umur 15 hingga 50 · Wanita · Dikemas kini 21 Sep 2026 · NCT06433765Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07606742Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
Mengambil pesertaFasa 2
Umur 18 hingga 120 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT02784210Clinical Applications of Advanced Ophthalmic Imaging
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 99 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT03135327Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 120 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT00001248RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
Mengambil peserta
Umur 18 hingga 65 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT05958381Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Mengambil pesertaFasa 3
Umur 18 hingga 60 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07325292Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Mengambil pesertaFasa 3
Umur 10 hingga 17 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06408259A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06680037Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 90 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06999434Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 2 hingga 120 · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT01730131Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
Mengambil peserta
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07132775Identifying and Characterizing Preclinical MS
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT05787795Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.